Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
SUPN
SUPN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SUPN News
Supernus Pharmaceuticals CEO to Attend Healthcare Conference
4d ago
Newsfilter
Supernus Pharmaceuticals Q1 2026 Earnings Highlights
5d ago
seekingalpha
Supernus Pharmaceuticals Q1 Earnings Beat Expectations
5d ago
seekingalpha
Supernus Pharmaceuticals to Announce Q1 Earnings on May 5
6d ago
seekingalpha
Alpha Cognition Appoints New Board Member
Apr 20 2026
Newsfilter
Unprofitable Companies Face Operational Challenges
Apr 14 2026
Yahoo Finance
Supernus Pharmaceuticals Enters Asset Purchase Agreement with Navitor
Apr 08 2026
seekingalpha
SUPERNUS PHARMACEUTICALS INC ACQUIRES ASSETS FOR NV-5138 OR SPN-820, INCLUDING INTELLECTUAL PROPERTY AND INVENTORY - SEC FILING
Apr 07 2026
moomoo
Supernus Executive Sells 107,250 Shares of Stock
Mar 27 2026
Fool
Supernus Pharmaceuticals Reports Q4 2025 Results and 2026 Guidance
Feb 25 2026
NASDAQ.COM
Supernus Pharmaceuticals Reports Record Q4 2025 Earnings and Strategic Progress
Feb 25 2026
seekingalpha
Supernus Pharmaceuticals Reports Strong Q4 2025 Earnings and Revenue Growth
Feb 25 2026
NASDAQ.COM
Supernus Pharmaceuticals Q4 2025 Earnings Exceed Expectations
Feb 24 2026
seekingalpha
Supernus Pharmaceuticals to Participate in Investor Conferences
Feb 23 2026
Newsfilter
Supernus Pharmaceuticals Q4 Earnings Announcement Scheduled
Feb 23 2026
seekingalpha
Strategic Shift in Biotech Dealmaking
Feb 17 2026
Globenewswire
Show More News
